Oral antiplatelet agent 1 is a potent P2Y12 receptor antagonist with strong antiplatelet aggregation activity (IC50 = 2.94 μM) and demonstrates antithrombotic effects in a rat ferric chloride-induced thrombosis model; it shows improved safety over clopidogrel in a rat tail bleeding model and can be used in the research of thromboembolic diseases.